For the treatment of paroxysmal nocturnal hemoglobinuria, the FDA has approved an oral factor B inhibitor.

Published Date: 08 Dec 2023

Transfusion is not necessary when using iptacopan, as it outperforms C5 Inhibitors in maintaining hemoglobin levels.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New Standard of Care in High-Risk Acute Promyelocytic Leukemia?

2.

Too Many Kids With Sickle Cell Disease Aren't Getting Appropriate Preventive Care

3.

Some low-grade prostate cancers carry higher risks than biopsy suggests

4.

Measurable Residual Disease Predicts Real-World AML Relapse

5.

The lack of psychiatrists may be addressed by community workers.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot